Eficácia de óleos minerais aplicados como adjuvantes auxiliando na selitividade de herbicidas na cultura de cana-de-açúcar

Pós-graduação em Agronomia - FEIS

Biodessulfurização do biogás gerado no processo de digestão anaeróbia da estação de tratamento de efluentes de uma indústria cervejeira

Pós-graduação em Química - IQ

Liberação controlada de nutrientes e novos sistemas para avaliação de espécies químicas empregadas na fertilização

Pós-graduação em Química - IQ

Detecção de anomalias por Floresta Caminhos Ótimos

Pós-graduação em Ciência da Computação - IBILCE

L3-arpsec - módulo seguro para controle e proteção do protocolo de resolução de endereços em redes definidas por software

Pós-graduação em Engenharia Elétrica - FEIS

Biosecurity in public and private office

Biosecurity is currently a concern for all health-related services, including dentistry, since infection control has a relevant importance. In dental practice, health-related occupations have contact with a great number of individuals who are potentially capable to transmit pathogens. This study comprised a descriptive evaluation of the universal precaution measures for infection control adopted by dental practitioners working at public and private offices in the city of Araçatuba, SP. Data collection was performed by a quiz with questions about individual and collective protection equipments. The results showed that the use of caps was reported by 55% of the professionals working at the public sector and 90% for the private sector. The use of masks and gloves was reported by all professionals surveyed; nevertheless, glove change between patients was not reported by 40% of professionals working at the public sector. There were more flaws in public offices as to the use of protective barriers, since except for the use of gloves, gowns and masks, the frequency of use of those barriers was smaller than at private offices.

Espectro de gotas e potencial de deriva de caldas contendo o herbicida 2,4-d amina em misturas em tanque

Pós-graduação em Agronomia (Energia na Agricultura) - FCA

Eficácia e ecotoxicidade do diquat em mistura com fontes de cobre para controle de Ceratophyllum demersum e alga unicelular e filamentosa

Pós-graduação em Agronomia (Produção Vegetal) - FCAV

Detecção de impressões digitais fraudulentas utilizando padrões mapeados localmente em multiescala

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

Detecção de impressões digitais falsas no reconhecimento biométrico de pessoas

Pós-graduação em Ciência da Computação - IBILCE

Avaliação do desenvolvimento reprodutivo de ratas fêmeas expostas in utero e durante a lactação a fungicidas (individuais ou misturados)

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

Projeto de adaptação do sistema de injeção do túnel transônico para ensaios em bocais de foguete

In this work, the project of a new experimental facility to be installed at the Aerodynamics Division of the Institute of Aeronautics and Space is presented. This new facility will provide means to perform experimental campaigns to analyze the flow behavior at different rocket nozzle concepts using cold gas that will be obtained from a modification of the Pilot Transonic Wind Tunnel air system. The new installation will enable less expensive experiments in a more secure environment, since the cold gas experimental procedures do not demand fuel storage and burn and security procedures are much less severe. Furthermore, experiments can be carried with different types of sensors, commonly used in wind tunnel tests. Also, the optical access is facilitated enabling the use of optical techniques for the characterization of flow properties inside the nozzles, such as pressure and temperature sensitive painting. The full project design and the operation conditions will be showed, as also some technical considerations about the flor behavior in the facility

Projeto de adaptação do sistema de injeção do túnel transônico para ensaios em bocais de foguete

In this work, the project of a new experimental facility to be installed at the Aerodynamics Division of the Institute of Aeronautics and Space is presented. This new facility will provide means to perform experimental campaigns to analyze the flow behavior at different rocket nozzle concepts using cold gas that will be obtained from a modification of the Pilot Transonic Wind Tunnel air system. The new installation will enable less expensive experiments in a more secure environment, since the cold gas experimental procedures do not demand fuel storage and burn and security procedures are much less severe. Furthermore, experiments can be carried with different types of sensors, commonly used in wind tunnel tests. Also, the optical access is facilitated enabling the use of optical techniques for the characterization of flow properties inside the nozzles, such as pressure and temperature sensitive painting. The full project design and the operation conditions will be showed, as also some technical considerations about the flor behavior in the facility

Re-treatment of previous non-responders and relapsers to interferon plus ribavirin with peginterferon alfa-2a (40KD), ribavirin +/- amantadine in patients with chronic hepatitis C: randomized multicentre clinical trial

Introduction. A large number of patients with chronic hepatitis C have not been cured with interferon-based therapy. Therefore, we evaluated the efficacy of amantadine combined with the standard of care (pegylated interferon plus ribavirin) in patients who had not responded to or had relapsed after 24 weeks of treatment with conventional interferon plus ribavirin. Material and methods. Patients stratified by previous response (i.e., non-response or relapse) were randomized to 48 weeks of open-label treatment with peginterferon alfa-2a (401(D) 180 pg/week plus ribavirin 1,000/1,200 mg/day plus amantadine 200 mg/day (triple therapy), or the standard of care (peginterferon alfa-2a [40KD] plus ribavirin). Results. The primary outcome was sustained virological response (SVR), defined as undetectable hepatitis C virus RNA in serum (< 50 IU/mL) at end of follow-up (week 72). Among patients with a previous non-response, 12/53 (22.6%; 95% confidence interval [CI] 12.3-36.2%) randomized to triple therapy achieved an SVR compared with 16/52 (30.8%; 95% CI 18.7-45.1%) randomized to the standard of care. Among patients with a previous relapse 22/39 (56.4%; 95% CI 39.6-72.2%) randomized to triple therapy achieved an SVR compared with 23/38 (60.5%; 95% CI 43.4-76.0%) randomized to the standard of care. Undetectable HCV RNA (< 50 IU/mL) at week 12 had a high positive predictive value for SVR. A substantial proportion of non-responders and relapsers to conventional interferon plus ribavirin achieve an SVR when re-treated with peginterferon alfa-2a (40KD) plus ribavirin. Conclusion. Amantadine does not enhance SVR rates in previously treated patients with chronic hepatitis C and cannot be recommended in this setting.

A Phase I clinical trial of lodenafil carbonate, a new phosphodiesterase Type 5 (PDE5) inhibitor, in healthy male volunteers

Lodenafil carbonate is a new phosphodiesterase Type 5 (PDE5) inhibitor used in treatment of erectile dysfunction. Objective: The present study was conducted to evaluate the safety, tolerability, and pharmacokinetics of lodenafil carbonate after administering ascending (1 - 100 mg) single oral doses to healthy male volunteers (n = 33). Methods: The study was an open-label, dose-escalation, Phase I clinical trial involving the administration of single oral doses of lodenafil carbonate. Lodenafil carbonate was administered sequentially, escalating in single doses of 1 mg - 100 mg with a washout period of at least 1 week between each dose. The progression to the next dose was allowed after clinical and laboratory exams, Ambulatory Monitoring of Arterial Pressure (AMAP) without relevant clinical modifications and adverse events without clinical relevancy. Blood samples were collected at pre-dose, 0.25, 0.5, 0.75, 1, 1.25, 1.5, 1.75, 2, 2.5, 3, 3.5, 4, 4.5, 5, 6, 7, 8, 10, 12, 14, 16, 20 and 24 h post-dosing. Plasma samples for measurement of lodenafil carbonate and lodenafil were analyzed by liquid chromatography coupled to tandem mass spectrometry. Results: No serious adverse events were observed, and none of the subjects discontinued the study due to intolerance. The AMAP measurements, clinical and laboratory exams and ECG revealed no significant changes even at higher doses. Lodenafil carbonate was not detected in any samples, indicating that it acts as a prodrug. The mean lodenafil pharmacokinetic parameters for t(max) and t(1/2) were 1.6 (+/- 0.4) h and 3.3 (+/- 1.1) h, respectively. This study demonstrated that lodenafil carbonate was well tolerated and showed a good safety profile in healthy male volunteers.